Dr. Yaron Ilan is the Director of the Department of Medicine at Hadassah Medical Center and a Professor of Medicine at Hebrew University. He specializes in inflammatory bowel diseases (IBD), liver diseases, and advanced endoscopic procedures.
With over 25 years of experience, Dr. Ilan has pioneered several treatment protocols for Crohn's disease and ulcerative colitis. He has published more than 200 scientific papers and serves on the editorial boards of multiple international gastroenterology journals. His research focuses on novel biologic therapies for IBD and non-invasive diagnostic techniques.
Dr. Ilan has received numerous awards including the Israeli Gastroenterology Association's Lifetime Achievement Award. He regularly trains medical students and residents, and has mentored over 50 gastroenterology specialists now practicing worldwide. His patient-centered approach combines cutting-edge treatments with personalized care plans.
Dr. Gabi Shefer is the Head of the Cardiology Department at Sheba Medical Center, Israel's largest hospital. He specializes in interventional cardiology, complex coronary interventions, and structural heart diseases.
With three decades of experience, Dr. Shefer has performed over 10,000 cardiac catheterizations and 5,000 angioplasties. He was among the first in Israel to implement transcatheter aortic valve implantation (TAVI) and has trained numerous cardiologists in this life-saving technique. His research on acute coronary syndromes has influenced treatment guidelines worldwide.
Dr. Shefer leads several international multicenter studies on novel anticoagulants and stent technologies. He has received the European Society of Cardiology's Gold Medal for his contributions to cardiovascular medicine. Patients praise his meticulous approach and ability to explain complex conditions in understandable terms.
Dr. Michal Lotem heads the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center. She is a world-renowned expert in immunotherapy for advanced cancers, particularly melanoma and renal cell carcinoma.
Over her 22-year career, Dr. Lotem has developed groundbreaking protocols combining checkpoint inhibitors with other modalities. Her work on adoptive cell therapy has shown remarkable success in metastatic melanoma cases deemed untreatable. She leads Israel's national melanoma tumor board and serves on the ESMO guidelines committee.
Dr. Lotem's research laboratory focuses on identifying biomarkers for immunotherapy response. She has published over 180 peer-reviewed articles and holds several patents for cancer treatment innovations. Despite her academic achievements, she remains deeply committed to patient care, known for her compassionate approach to cancer patients and their families.
Dr. David Lichtstein is the Director of Neurosurgery at Tel Aviv Sourasky Medical Center (Ichilov Hospital). He specializes in complex brain and spine surgeries, with particular expertise in tumor resection and minimally invasive techniques.
With nearly three decades of experience, Dr. Lichtstein has performed over 6,000 neurosurgical procedures. He pioneered awake craniotomies in Israel for tumor removal in eloquent brain areas, significantly improving outcomes for patients with gliomas. His work on spinal cord stimulation for chronic pain has provided relief to hundreds of patients.
Dr. Lichtstein developed several surgical instruments now used internationally and holds professorships at both Tel Aviv University and the Technion. He combines exceptional technical skills with a holistic approach, considering each patient's unique neurological and psychological needs. His residents describe him as a demanding but inspiring teacher who sets the highest standards.
Professor Dina Ben-Yehuda is the Head of Hematology at Hadassah Medical Center and former Dean of the Hebrew University Medical School. She is Israel's foremost expert in malignant hematology, particularly leukemias and lymphomas.
With an illustrious 35-year career, Prof. Ben-Yehuda has transformed treatment protocols for acute myeloid leukemia (AML), improving survival rates significantly. She established Israel's first comprehensive bone marrow transplantation program and has overseen over 2,000 transplants. Her research on minimal residual disease detection has become standard practice worldwide.
Internationally recognized, Prof. Ben-Yehuda has served as president of the European Hematology Association and on numerous WHO committees. Despite her administrative and research responsibilities, she maintains an active clinical practice, known for her diagnostic acumen and unwavering dedication to even the most challenging cases. Many of her former trainees now head hematology departments across Israel.
Dr. Eyal Leshem directs the Center for Travel Medicine and Tropical Diseases at Sheba Medical Center. He specializes in emerging infectious diseases, tropical medicine, and travel-related illnesses.
With 18 years of experience, Dr. Leshem has become Israel's leading expert on outbreak management, playing key roles during the COVID-19 pandemic, MERS outbreaks, and regional emerging infections. He developed national protocols for antimicrobial stewardship that reduced resistant infections in Israeli hospitals by 40%.
Dr. Leshem advises the Israeli Ministry of Health on pandemic preparedness and serves as a consultant to the WHO on emerging pathogens. His research on rapid diagnostics for febrile illnesses in travelers has changed clinical practice globally. Despite his public health focus, he maintains an active clinical practice, known for solving complex diagnostic puzzles in returning travelers.
Professor Rafael Beyar is the former Director General of Rambam Health Care Campus and a pioneer in interventional cardiology. He specializes in complex coronary interventions and innovative cardiac technologies.
With 32 years of groundbreaking work, Prof. Beyar developed several angioplasty techniques now used worldwide. He co-invented the first robotic system for coronary interventions and holds numerous patents for medical devices. His research on stent design has influenced generations of coronary implants.
Beyond clinical innovations, Prof. Beyar transformed Rambam into a leading academic medical center, establishing its underground emergency hospital. He has trained hundreds of cardiologists and received Israel's highest medical honor, the Sieff Prize. Patients appreciate his ability to explain complex heart conditions with clarity and optimism.
Dr. Irit Ben-Aharon heads the Breast Cancer Center at Tel Aviv Sourasky Medical Center. She specializes in young women with breast cancer and fertility preservation strategies.
Over 15 years, Dr. Ben-Aharon has developed innovative protocols for preserving fertility in cancer patients undergoing chemotherapy. Her work on ovarian suppression during treatment has enabled hundreds of young women to conceive after cancer. She leads Israel's national guidelines committee for breast cancer in young women.
Dr. Ben-Aharon's research focuses on the molecular biology of hormone-sensitive breast cancers. She has established multidisciplinary clinics addressing all aspects of women's health after breast cancer. Patients value her compassionate approach and dedication to their long-term quality of life beyond cancer survival.
Professor Itamar Raz is the Director of the Diabetes Unit at Hadassah Medical Center and former president of the International Diabetes Federation. He is Israel's most renowned diabetes specialist.
With four decades of experience, Prof. Raz has been instrumental in developing new diabetes medications and treatment algorithms. He led several landmark international trials that changed diabetes management worldwide. His work on early intensive treatment to preserve beta cell function has become standard practice.
Prof. Raz established Israel's national diabetes council and prevention programs. Despite his global leadership role, he maintains a busy clinical practice, known for his personalized approach combining cutting-edge treatments with lifestyle modification strategies. He has trained generations of endocrinologists who now lead diabetes programs across Israel.
Dr. Jacob Lavee is the Director of the Heart Transplantation Unit at Sheba Medical Center, Israel's busiest transplant program. He specializes in complex heart surgeries and mechanical circulatory support.
With 30 years of experience, Dr. Lavee has performed over 1,000 heart transplants and implanted more than 500 ventricular assist devices (VADs). He pioneered Israel's first successful artificial heart implantation and developed protocols that have significantly reduced transplant rejection rates.
Dr. Lavee's research on donor heart preservation has extended the viability window for transplants. He established Israel's national heart allocation system, ensuring equitable access to this life-saving treatment. Patients and families praise his surgical skill combined with exceptional emotional support throughout the transplant journey.
Professor Shlomo Mor-Yosef is the former Director General of Hadassah Medical Organization and a leading expert in high-risk pregnancies and gynecologic oncology.
With 35 years of experience, Prof. Mor-Yosef has managed thousands of complex pregnancies and developed protocols now used nationwide. His work on cervical cancer screening in pregnant women has significantly improved early detection rates. He established Israel's first multidisciplinary clinic for pregnancy with cancer.
Beyond clinical work, Prof. Mor-Yosef transformed Hadassah into a world-class medical center during his tenure. He has served as president of the International Federation of Fertility Societies and advises governments on reproductive health policies. Despite administrative roles, he continues to deliver babies and care for patients, known for his calm demeanor in obstetric emergencies.
Dr. Dan Engelhard heads the Pediatric Infectious Disease Unit at Hadassah Medical Center. He specializes in immunocompromised children, vaccine development, and emerging pediatric infections.
With 28 years of experience, Dr. Engelhard has treated thousands of children with complex infections. His research on preventing infections in pediatric cancer patients has reduced mortality rates significantly. He played a key role in developing Israel's national immunization program and several novel vaccines.
Dr. Engelhard advises the WHO on pediatric immunization strategies and leads international studies on antimicrobial resistance in children. Despite his research commitments, he maintains an active clinical practice, known for his ability to comfort both patients and parents during difficult treatments. His former trainees now lead pediatric infectious disease units across Israel.
Professor Nir Giladi chairs the Neurological Institute at Tel Aviv Sourasky Medical Center and specializes in movement disorders, particularly Parkinson's disease and related conditions.
With 25 years of experience, Prof. Giladi has developed innovative treatment protocols that have improved quality of life for thousands of Parkinson's patients. His research on early biomarkers for Parkinson's has been groundbreaking, potentially enabling neuroprotective interventions before significant damage occurs.
Prof. Giladi leads several international research consortia on neurodegenerative diseases and has established multidisciplinary clinics addressing all aspects of Parkinson's care. Patients appreciate his comprehensive approach that addresses both motor and non-motor symptoms. He has trained most of Israel's current movement disorder specialists.
Dr. Mordechai Kramer directs the Pulmonary Institute at Rabin Medical Center, specializing in interstitial lung diseases and pulmonary fibrosis.
With 22 years of experience, Dr. Kramer has established Israel's most comprehensive interstitial lung disease program. His work on early diagnosis and treatment of pulmonary fibrosis has significantly improved outcomes. He was among the first in Israel to implement anti-fibrotic therapies and lung transplantation for these conditions.
Dr. Kramer leads national guidelines committees for rare lung diseases and has developed novel diagnostic algorithms combining imaging with molecular markers. Patients value his thorough evaluations and commitment to exploring all treatment options. His research collaborations span multiple countries, advancing understanding of these challenging conditions.
Professor Eyal Mishani heads the Nuclear Medicine Department at Hadassah Medical Center and is a world leader in molecular imaging and theranostics.
With 20 years of experience, Prof. Mishani has developed several novel radiopharmaceuticals for cancer diagnosis and treatment. His work on PSMA-targeted therapies for prostate cancer has provided new hope for patients with advanced disease. He established Israel's first comprehensive theranostics program combining diagnosis and targeted radiation treatment.
Prof. Mishani holds numerous patents for imaging agents and leads international collaborations advancing nuclear medicine. Despite his research focus, he remains deeply involved in patient care, personally overseeing complex cases. His trainees now lead nuclear medicine departments across Israel and Europe.
Dr. Tami Karni heads the Plastic Surgery Department at Sheba Medical Center, specializing in microsurgical reconstruction and gender-affirming surgeries.
With 18 years of experience, Dr. Karni has performed thousands of complex reconstructions following cancer, trauma, or congenital conditions. She pioneered Israel's most comprehensive gender-affirmation surgery program, combining surgical expertise with holistic care. Her techniques for DIEP flap breast reconstruction have set new standards.
Dr. Karni's research focuses on improving outcomes in microvascular surgery and reducing complications. She has trained numerous plastic surgeons now practicing worldwide. Patients appreciate her artistic eye combined with surgical precision, as well as her compassionate approach to life-changing procedures.
Professor Avraham Karasik is the Director of the Diabetes and Metabolism Unit at Sheba Medical Center and a leading expert in diabetes genetics and personalized medicine.
With 30 years of experience, Prof. Karasik has identified several genetic variants influencing diabetes risk and treatment response. His work has enabled more targeted approaches to diabetes prevention and management. He established Israel's first clinic for monogenic diabetes, correctly diagnosing hundreds of patients previously misclassified.
Prof. Karasik leads international consortia studying the genetics of diabetes complications. Despite his research focus, he maintains an active clinical practice, known for his encyclopedic knowledge and individualized treatment plans. He has mentored generations of endocrinologists now leading diabetes programs worldwide.
Dr. Orly Avnur directs the Pediatric Echocardiography Laboratory at Schneider Children's Medical Center, Israel's leading pediatric heart facility.
With 20 years of experience, Dr. Avnur has performed over 15,000 pediatric echocardiograms and specializes in fetal cardiology. Her expertise in diagnosing congenital heart defects in utero has enabled life-saving interventions immediately after birth. She developed protocols now used nationwide for screening newborns for critical congenital heart disease.
Dr. Avnur's research focuses on improving outcomes for hypoplastic left heart syndrome and other complex defects. Parents appreciate her ability to explain complex conditions with clarity and compassion. She has trained most of Israel's current pediatric cardiologists in advanced echocardiography techniques.
Professor Yaakov Naparstek is the former Head of Rheumatology at Hadassah Medical Center and Israel's foremost expert in autoimmune diseases.
With 35 years of experience, Prof. Naparstek has transformed treatment approaches for lupus, rheumatoid arthritis, and vasculitis. His research on B-cell targeting therapies paved the way for rituximab's use in autoimmune conditions. He established Israel's first dedicated lupus clinic and national registry, improving care coordination.
Prof. Naparstek has served as president of the Israel Rheumatology Association and on numerous international committees developing treatment guidelines. Despite retiring from administrative roles, he continues to see patients, valued for his diagnostic acumen and ability to manage complex, treatment-resistant cases.
Dr. Adi Leiba heads the Emergency Department at Rambam Health Care Campus, northern Israel's largest trauma center.
With 15 years of experience, Dr. Leiba has treated thousands of trauma cases and mass casualty events. He developed innovative protocols for field triage and damage control resuscitation that have been adopted by the IDF and emergency services nationwide. His work on hemorrhage control has significantly reduced preventable deaths.
Dr. Leiba leads Israel's national emergency medicine training program and has established simulation centers improving preparedness. Colleagues admire his calm under pressure and ability to coordinate complex emergency responses. Despite administrative duties, he continues regular shifts in the ER, believing leadership must remain clinically engaged.
Professor Haim Mayan directs the Nephrology and Hypertension Institute at Assuta Medical Center, specializing in complex kidney diseases and hypertension.
With 25 years of experience, Prof. Mayan has managed thousands of patients with kidney failure, developing personalized approaches to slow disease progression. His research on resistant hypertension has identified novel treatment pathways. He established Israel's first clinic for rare kidney diseases, correctly diagnosing many patients after years of uncertainty.
Prof. Mayan leads international studies on kidney protection strategies and serves on guideline committees for hypertension management. Patients appreciate his comprehensive evaluations and commitment to exploring all options before dialysis. His former trainees now lead nephrology departments across Israel.
Dr. Michal Gur heads the Geriatric Medicine Department at Rabin Medical Center, specializing in dementia care and frailty syndromes.
With 20 years of experience, Dr. Gur has developed comprehensive assessment protocols that identify reversible components of cognitive decline. Her work on multidomain interventions has shown remarkable success in preventing dementia progression. She established Israel's first memory clinic combining medical, social, and therapeutic approaches.
Dr. Gur leads national initiatives to improve care for elderly patients and reduce inappropriate polypharmacy. Patients and families value her holistic approach that considers medical, social, and psychological factors. She has trained most of Israel's current geriatricians, elevating standards of care for the elderly nationwide.
Professor Aviram Nissan is the Head of Surgical Oncology at Sheba Medical Center, specializing in complex gastrointestinal and peritoneal malignancies.
With 22 years of experience, Prof. Nissan has performed thousands of cancer surgeries, pioneering cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced abdominal cancers. His work has extended survival for patients previously considered untreatable. He developed protocols now used internationally for patient selection in these complex procedures.
Prof. Nissan leads research on tumor microenvironment and surgical outcomes, with over 300 publications. Despite his academic productivity, he remains deeply committed to patient care, known for his meticulous surgical technique and compassionate approach to cancer patients facing difficult decisions.
Dr. Yael Mozer-Glassberg directs the Pediatric Liver Unit at Schneider Children's Medical Center, Israel's leading pediatric liver transplant program.
With 18 years of experience, Dr. Mozer-Glassberg has managed hundreds of children with complex liver diseases and performed over 100 liver transplants. Her work on living donor transplantation for metabolic diseases has enabled curative treatment without waiting for cadaveric donors. She developed protocols now used internationally for post-transplant management in children.
Dr. Mozer-Glassberg's research focuses on improving long-term outcomes for pediatric transplant recipients. Parents appreciate her availability and ability to explain complex medical information with patience and clarity. She has trained numerous pediatric hepatologists now practicing across Israel and Europe.
Professor Dan Admon chairs the Otolaryngology Head and Neck Surgery Department at Rambam Health Care Campus, specializing in skull base surgery and hearing restoration.
With 28 years of experience, Prof. Admon has performed thousands of complex ear and skull base procedures. He pioneered endoscopic approaches to pituitary tumors and acoustic neuromas, reducing complications and recovery times. His work on cochlear implantation has restored hearing to hundreds of children and adults.
Prof. Admon developed several surgical instruments now used worldwide and holds professorships at the Technion. Patients appreciate his calm demeanor and willingness to explore all options. He has trained generations of ENT surgeons, many now leading departments in Israel and abroad.
Dr. Revital Kariv heads the Inflammatory Bowel Disease Center at Tel Aviv Sourasky Medical Center, specializing in Crohn's disease and ulcerative colitis.
With 16 years of experience, Dr. Kariv has developed personalized treatment algorithms that have significantly improved outcomes for IBD patients. Her research on predicting treatment response using genetic markers has enabled more targeted therapies. She established Israel's first comprehensive IBD clinic addressing both medical and nutritional aspects.
Dr. Kariv leads national guidelines committees for IBD management and has implemented innovative telemedicine programs improving access to care. Patients appreciate her holistic approach and dedication to their long-term quality of life. She has trained numerous gastroenterologists now specializing in IBD across Israel.
Professor Eitan Kerem is the former Dean of the Hebrew University Medical School and Director of Pediatrics at Hadassah Medical Center, specializing in cystic fibrosis.
With 30 years of experience, Prof. Kerem has transformed cystic fibrosis care in Israel, establishing the nation's first accredited CF center. His research on CFTR modulators has provided life-changing treatments for many patients. He identified several novel CF mutations common in Middle Eastern populations, improving diagnosis rates.
Prof. Kerem has served as president of the European Society for Pediatric Research and on numerous international committees. Despite administrative roles, he maintains an active clinical practice, known for his long-term relationships with CF patients from infancy through adulthood. His work has dramatically improved life expectancy for Israeli CF patients.
Dr. Amir Onn directs the Thoracic Cancer Unit at Sheba Medical Center, specializing in lung cancer and mesothelioma.
With 20 years of experience, Dr. Onn has pioneered minimally invasive diagnostic and treatment approaches for thoracic malignancies. His work on targeted therapies for non-small cell lung cancer has personalized treatment based on molecular profiling. He established Israel's first comprehensive lung cancer screening program for high-risk individuals.
Dr. Onn leads research on early detection biomarkers and novel immunotherapies. Patients appreciate his willingness to explore all treatment options and his compassionate approach to difficult diagnoses. He has trained numerous oncologists now specializing in thoracic malignancies across Israel.
Professor Shlomo Vinker is the Head of Family Medicine at Clalit Health Services, Israel's largest HMO, and a leading expert in primary care innovation.
With 25 years of experience, Prof. Vinker has transformed primary care delivery through digital health solutions and team-based models. His research on preventive medicine strategies has influenced national screening programs. He developed Israel's first comprehensive chronic disease management programs in primary care.
Prof. Vinker advises the Ministry of Health on primary care policy and has trained generations of family physicians. Patients value his holistic approach addressing physical, emotional, and social health determinants. Despite administrative roles, he maintains an active clinical practice, believing leaders should remain grounded in patient care realities.
Dr. Orna Steinberg-Shemer heads the Pediatric Hematology Unit at Dana-Dwek Children's Hospital (Tel Aviv Sourasky), specializing in bleeding disorders and bone marrow failure syndromes.
With 15 years of experience, Dr. Steinberg-Shemer has managed hundreds of children with complex hematologic conditions. Her work on gene therapy for hemophilia has positioned Israel at the forefront of this transformative treatment. She established comprehensive clinics for rare bleeding disorders, improving diagnosis and management.
Dr. Steinberg-Shemer leads research on novel therapies for bone marrow failure and serves on international guideline committees. Parents appreciate her patience in explaining complex conditions and her dedication to long-term follow-up. She has trained numerous pediatric hematologists now caring for children across Israel.